MAPK3 and cancer: This prolonged activation of ERK1/2 promotes uncontrolled cell growth and survival, which are hallmark featuresof cancer [10], [11] Moreover, ERK1/2 signaling cancrosstalk with other signaling pathways implicated in cancer, thereby amplifying oncogenic signaling networks.